Cycurion Continues Expansion in Public Health Sector with New Multi-Year Awards Totaling Approximately $1.35 Million in Annual Recurring Revenue
Rhea-AI Summary
Cycurion (Nasdaq: CYCU) won two public-health contracts expected to generate approximately $1.35 million in combined 2026 revenue, including $1.165 million in new annual recurring revenue (ARR).
The awards include a one-year task order under a potential 10-year framework with a large healthcare government agency and an expanded engagement with NACCHO, focused on secure cloud public-health systems, cybersecurity, resiliency, and cloud infrastructure.
Positive
- New ARR of $1.165 million
- Expected $1.35 million combined revenue in 2026
- One-year task order under a potential 10-year framework
- Expanded contract with NACCHO adding $185,000 in 2026
Negative
- None.
News Market Reaction – CYCU
In the Mar 25 session, CYCU gained 4.35%, reflecting a moderate positive market reaction. Argus tracked a trough of -12.8% from its starting point during tracking. Our momentum scanner triggered 6 alerts that day, indicating moderate trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Mar 17 | Unauthorized PR response | Negative | +19.4% | Company refuted a false >$150M acquisition release and detailed legal actions. |
| Mar 16 | Acquisition & backlog | Positive | -22.0% | Announced EPS-accretive federal cybersecurity acquisition and backlog above $150M. |
| Feb 26 | Special meeting delay | Neutral | +0.0% | Adjourned special meeting on approval to issue up to 3,314,920 warrant shares. |
| Feb 11 | Cost efficiency plan | Positive | -4.1% | Reorganization targeting about $2.2M 2026 cost efficiencies and CRO appointment. |
| Feb 03 | Analyst initiation | Positive | -1.0% | Buy rating with $7 target citing $80M backlog and valuation metrics. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
CYCU has frequently sold off or traded flat on ostensibly positive news, with multiple divergences where upbeat announcements coincided with negative or muted price reactions.
Over the last few months, Cycurion reported analyst coverage with a $7 target, a strategic reorganization targeting $2.2M in annualized savings, and a definitive acquisition expected to be EPS accretive with added ARR. It also disclosed a large, growing contracted backlog and addressed an unauthorized acquisition press release tied to trading volatility. Against that backdrop, today’s new public health awards and added ARR extend the narrative of expanding backlog and government-sector footprint.
Key Terms
annual recurring revenue financial
arr financial
cloud infrastructure technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
MCLEAN, Va., March 25, 2026 (GLOBE NEWSWIRE) -- Cycurion, Inc. (Nasdaq: CYCU) (“Cycurion” or the “Company”), a trusted leader in IT cybersecurity and AI-driven solutions, today announced continued momentum in the public health domain with two new contract awards. These awards are expected to generate approximately
The awards include a multi-year engagement with a large healthcare government agency and an expanded relationship with the National Association of County and City Health Officials (NACCHO). The scope of work focuses on implementing and supporting a secure, cloud-based public health system, incorporating advanced cybersecurity, enterprise resiliency, and cloud infrastructure capabilities.
“These strategic wins in public health, combined with our ongoing expansion into public safety, demonstrate our continued leadership in delivering secure, resilient technology solutions to critical government sectors at a time when protecting community infrastructure has never been more important,” said Kevin Kelly, Chairman and CEO of Cycurion. “We remain focused on driving profitable growth while building predictable, high-margin recurring revenue.”
The agency award represents an initial one-year task order under a potential 10-year framework, with an estimated ARR of
“Public health agencies rely on secure, cloud-based systems to deliver essential services every day — and we’re proud to help ensure those systems are protected and resilient against evolving threats,” added Kelly. “These awards highlight our ability to execute complex implementations that directly support mission success and community well-being.”
About Cycurion, Inc.
Based in McLean, Virginia, Cycurion (NASDAQ: CYCU) is a forward-thinking provider of IT cybersecurity solutions and AI, committed to delivering secure, reliable, and innovative services to clients worldwide. Specializing in cybersecurity, program management, and business continuity, Cycurion harnesses its AI-enhanced ARx platform and expert team to empower clients and safeguard their operations. Along with its subsidiaries, Axxum Technologies LLC, Cloudburst Security LLC, and Cycurion Innovation, Inc., Cycurion serves government, healthcare, and corporate clients committed to securing the digital future. For more information, visit www.cycurion.com.
Forward-Looking Statements
This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to the operations and prospective growth of Cycurion’s business.
Certain statements in this press release that are not historical facts are forward-looking statements within the meaning of Section 27A of the Securities Exchange Act of 1934, as amended. Any statements contained in this press release that are not statements of historical fact may be deemed forward-looking statements. Such statements include, but are not limited to, statements regarding the anticipated closing of the offering; the Company’s anticipated use of proceeds from the offering; the acceleration of the Company’s inorganic growth strategy; the continued execution on the Company’s backlog; and other statements that are not historical facts, including statements which may be accompanied by words such as “continue,” “will,” “may,” “could,” “should,” “expect,” “expected,” “plans,” “intend,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” and similar expressions are intended to identify such forward-looking statements. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements, many of which are generally outside the control of Cycurion and are difficult to predict. Examples of such risks and uncertainties include, but are not limited to, the outcomes of the Company’s investigations, any potential legal proceedings, or the future performance of the Company’s stock. Additional factors that could cause actual results to differ materially from those expressed or implied in the forward-looking statements can be found in the most recent annual report on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K filed by Cycurion with the U.S. Securities and Exchange Commission. Cycurion anticipates that subsequent events and developments may cause its plans, intentions, and expectations to change. Cycurion assumes no obligation, and it specifically disclaims any intention or obligation, to update any forward-looking statements, whether as a result of new information, future events, or otherwise, except as expressly required by law. Forward-looking statements speak only as of the date they are made and should not be relied upon as representing Cycurion’s plans and expectations as of any subsequent date.
Cycurion Investor Relations:
(888) 341-6680
investors@cycurion.com
Cycurion Media Relations:
(888) 341-6680
media@cycurion.com
